Changes in US stocks | Brain Regeneration Technology (RGC.US) continued to rise by nearly 20% before the market and continued to rise 157% in three trading days

The Zhitong Finance App learned that on Thursday, Brain Regeneration Technology (RGC.US) continued to rise by nearly 20% before the market. The previous three trading days had a cumulative increase of 157%, and is now at $62.94. According to the news, Musk recently stated on social media that its brain-computer interface company Neuralink will begin “large-scale production” of brain-computer interface devices in 2026. It also simultaneously promotes a surgical plan with a highly streamlined and almost fully automated procedure. The most critical breakthrough is that the electrode wire in the device will directly pass through the dura mater without removing it.

Domestically, on January 7, eight departments including the Ministry of Industry and Information Technology jointly issued the “Implementation Opinions on the “Artificial Intelligence+Manufacturing” Special Action, clearly stating that the industrialization and commercialization process of new terminals such as brain-computer interfaces (BCI) will be accelerated.

The analysis points out that with the combined efforts of technological breakthroughs, policy drivers, and global industrial resonance, brain-computer interfaces are rapidly moving from a cutting-edge scientific concept to a “key leap forward” in commercialization and industrialization.